Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.64M Sell
20,966
-3,698
-15% -$758K 0.02% 492
2025
Q4
$6.32M Buy
+24,664
New +$6.47M 0.03% 410
2025
Q1
$16.7M Buy
62,997
+36,906
+141% +$9.98M 0.09% 212
2024
Q4
$6.62M Buy
26,091
+373
+1% +$100K 0.03% 391
2024
Q3
$8.15M Buy
25,718
+1,813
+8% +$645K 0.04% 391
2024
Q2
$8.93M Buy
23,905
+4,137
+21% +$1.4M 0.05% 369
2024
Q1
$6.85M Sell
19,768
-106,121
-84% -$40.2M 0.03% 399
2023
Q4
$57.6M Buy
125,889
+14,282
+13% +$7.04M 0.3% 85
2023
Q3
$54.3M Buy
111,607
+31,397
+39% +$14.8M 0.31% 82
2023
Q2
$38.9M Sell
80,210
-64
-0.1% -$32.2K 0.22% 107
2023
Q1
$39M Buy
80,274
+65,866
+457% +$32.6M 0.22% 107
2022
Q4
$7.38M Buy
14,408
+7,411
+106% +$3.9M 0.04% 366
2022
Q3
$3.39M Sell
6,997
-154
-2% -$74.9K 0.02% 433
2022
Q2
$3.35M Buy
7,151
+47
+0.7% +$20.9K 0.02% 452
2022
Q1
$3.09M Sell
7,104
-6,337
-47% -$2.65M 0.02% 487
2021
Q4
$6.23M Sell
13,441
-934
-6% -$413K 0.03% 412
2021
Q3
$5.59M Sell
14,375
-6,613
-32% -$2.81M 0.03% 405
2021
Q2
$9.29M Sell
20,988
-3,435
-14% -$1.5M 0.05% 349
2021
Q1
$10.2M Buy
24,423
+2,185
+10% +$872K 0.06% 324
2020
Q4
$9.12M Sell
22,238
-1,920
-8% -$798K 0.05% 337
2020
Q3
$10M Sell
24,158
-11,816
-33% -$4.75M 0.06% 302
2020
Q2
$13.9M Buy
35,974
+96
+0.3% +$35.9K 0.09% 266
2020
Q1
$13.1M Hold
35,878
0.06% 328
2019
Q4
$13.1M Sell
35,878
-75,903
-68% -$24.1M 0.06% 328
2019
Q3
$28.6K Sell
111,781
-134,419
-55% -$37.7M 0.13% 212
2019
Q2
$65.3K Buy
246,200
+32,119
+15% +$8.15M 0.29% 93
2019
Q1
$56.9K Buy
214,081
+138,977
+185% +$40M 0.26% 106
2018
Q4
$21.5K Sell
75,104
-367,029
-83% -$116M 0.1% 271
2018
Q3
$150M Sell
442,133
-58,133
-12% -$18.9M 0.6% 28
2018
Q2
$149M Buy
500,266
+303,080
+154% +$88.8M 0.66% 26
2018
Q1
$48.9M Hold
197,186
0.2% 146
2017
Q4
$48.9M Buy
197,186
+5,797
+3% +$1.43M 0.2% 146
2017
Q3
$46.6M Buy
191,389
+174,155
+1,011% +$42.7M 0.2% 146
2017
Q2
$3.55M Hold
17,234
0.02% 530
2017
Q1
$3.55M Buy
17,234
+7,385
+75% +$1.53M 0.02% 530
2016
Q4
$2.01M Sell
9,849
-193
-2% -$36.8K 0.01% 627
2016
Q3
$1.77M Sell
10,042
-104
-1% -$18K 0.01% 648
2016
Q2
$1.82M Sell
10,146
-6,462
-39% -$1.15M 0.01% 637
2016
Q1
$3.04M Sell
16,608
-997
-6% -$173K 0.02% 525
2015
Q4
$3.14M Sell
17,605
-557
-3% -$97.8K 0.02% 511
2015
Q3
$3.25M Sell
18,162
-36,321
-67% -$6.71M 0.02% 479
2015
Q2
$10.4M Sell
54,483
-13,398
-20% -$2.49M 0.08% 342
2015
Q1
$12.1M Sell
67,881
-6,480
-9% -$1.03M 0.09% 327
2014
Q4
$10.7M Sell
74,361
-34,484
-32% -$4.71M 0.08% 333
2014
Q3
$14.2M Buy
108,845
+66,976
+160% +$8.51M 0.12% 244
2014
Q2
$5.35M Buy
41,869
+2,964
+8% +$351K 0.05% 400
2014
Q1
$4.38M Sell
38,905
-1,935
-5% -$202K 0.04% 422
2013
Q4
$4.21M Buy
40,840
+11,944
+41% +$1.17M 0.04% 414
2013
Q3
$2.7M Sell
28,896
-55,018
-66% -$5.05M 0.03% 472
2013
Q2
$7.08M Buy
+83,914
New +$6.62M 0.09% 256

Other funds holding HUM

Glenmede Trust's HUM Position: Q1 2026 in Review

Glenmede Trust reduced its Humana (HUM) stake by 15% in Q1 2026, selling an estimated $758K and leaving 20,966 shares worth $3.64M. The position accounts for 0.02% of the portfolio, ranked #492.

Glenmede Trust first reported a position in HUM in Q2 2013 and has held it in 50 quarters since. The position peaked at $150M in Q3 2018. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Glenmede Trust held 20,966 shares of Humana worth $3.64M as of Q1 2026.
  • Glenmede Trust sold 3,698 Humana shares in Q1 2026, an estimated $758K.
  • Humana made up 0.02% of Glenmede Trust's portfolio in Q1 2026, its #492 holding.
  • Glenmede Trust first reported a position in Humana in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Humana position peaked at $150M in Q3 2018.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.